Trimethoprim-sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis.
D000368:Aged; D001991:Bronchitis / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D008297:Male; D010919:Placebos; D013183:Sputum / Q000187:drug effects / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013492:Suppuration / Q000188:drug therapy; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D010919:Placebos; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole